78 results match your criteria Interstitial Laser Coagulation of the Prostate


Usage of GreenLight HPS 180-W laser vaporisation for treatment of benign prostatic hyperplasia.

Acta Chir Iugosl 2014 ;61(1):57-61

Introduction: Laser therapy has gained increasing acceptance as a relatively less invasive treatment for lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). From the early procedure of interstitial laser coagulation through to the use of holmium laser enucleation of the prostate, there has been an expanding body of evidence on the efficacy of such procedures. One of the newer lasers is the Green Light HPS 180 W laser. Read More

View Article

Download full-text PDF

Source
October 2015
4 Reads

Combination of channel-TURP and ILC versus standard TURP or ILC for elderly with benign prostatic hyperplasia: a randomized prospective trial.

Urol Int 2011 30;87(4):392-9. Epub 2011 Sep 30.

Department of Urology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Purpose: A prospective randomized controlled trial was performed in elderly patients with benign prostatic hyperplasia (BPH) to evaluate the clinical effectiveness of channel transurethral resection of the prostate (C-TURP) combined with an interstitial laser coagulation (ILC) technique during a 4-year follow-up period.

Methods: A total of 150 consecutive BPH patients were randomized to an ILC+C-TURP group (n = 50), an ILC group (n = 50) and a TURP group (n = 50). Urinary tract infection, acute urinary retention and retrograde ejaculation were monitored, and the retreatment rate, international prostate symptom score (IPSS) and maximum flow rate (Q(max)) were measured. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000331500DOI Listing
April 2012
4 Reads

Laser vaporization of the prostate in vivo: Experience with the 150-W 980-nm diode laser in living canines.

Lasers Surg Med 2010 Oct;42(8):736-42

Department of Urology, University Hospital Basel, Basel, Switzerland.

Background And Objective: Anatomic, tissue ablation and coagulation, and histopathologic outcomes of the 150-W 980-nm diode laser selective light vaporization (SLV™) of the prostate in the first survival study of living canines were analyzed.

Study Design/materials And Methods: Ten dogs underwent anterograde SLV™ with the 150-W 980-nm laser delivered by its side-firing fiber (Fusion™). Postoperatively, two dogs were euthanized at 3 hours as planned, six at 2-7 days due to complications, and two, without complications, at 8 weeks as planned. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/lsm.20966DOI Listing
October 2010
7 Reads

The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review.

Asian J Androl 2010 Jul 17;12(4):500-8. Epub 2010 May 17.

Division of Urology, University of Texas Medical School at Houston, Houston, TX 77030, USA.

A systematic review of randomized controlled trials and cohort studies was conducted to evaluate data for the effects of minimally invasive procedures for treatment of symptomatic benign prostatic hyperplasia (BPH) on male sexual function. The studies searched were trials that enrolled men with symptomatic BPH who were treated with laser surgeries, transurethral microwave therapy (TUMT), transurethral needle ablation of the prostate (TUNA), transurethral ethanol ablation of the prostate (TEAP) and high-intensity frequency ultrasound (HIFU), in comparison with traditional transurethral resection of the prostate (TURP) or sham operations. A total of 72 studies were identified, of which 33 met the inclusion criteria. Read More

View Article

Download full-text PDF

Source
http://www.asiaandro.com/Abstract.asp?doi=10.1038/aja.2010.3
Publisher Site
http://dx.doi.org/10.1038/aja.2010.33DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739367PMC
July 2010
6 Reads

Laser treatments of the prostate vs TURP/ open prostatectomy: systematic review of urodynamic data.

Minerva Urol Nefrol 2009 Sep;61(3):309-24

Department of Urology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.

Unlabelled: Bladder outlet obstruction (BOO) is believed to be the major component of benign prostatic hyperplasia (BPH) that harms the urinary tract. Therefore, BOO relief is the primary treatment objective in patients with obstructive BPH. This systematic review aims to analyze urodynamic data of laser treatment modalities of the prostate in direct comparison with standard treatment (TURP or open prostatectomy). Read More

View Article

Download full-text PDF

Source
September 2009
1 Read

[Surgical and instrumental management of benign prostatic hyperplasia].

Authors:
R Muschter O Reich

Urologe A 2008 Feb;47(2):155-65

Klinik für Urologie und Kinderurologie, Diakoniekrankenhaus Rotenburg/W., Akad. Lehrkrankenhaus der Universität Göttingen, 27356, Rotenburg.

In recent decades, several various interventional procedures for the treatment of symptomatic benign prostatic hyperplasia (BPH) have been developed. Most of them were considered potential alternatives to prostatic surgery such as open prostatectomy, transurethral resection of the prostate (TURP), or transurethral incision of the prostate (TUIP). Despite good results observed in the initial clinical studies, most concepts and procedures were never generally accepted. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00120-008-1630-8DOI Listing
February 2008
1 Read

New laser treatment approaches for benign prostatic hyperplasia.

Curr Urol Rep 2007 Jan;8(1):47-52

Department of Physics and Optical Science, University of North Carolina at Charlotte, 9201 University City Boulevard, Charlotte, NC 28223-0001, USA.

The recent introduction of higher power 100 W holmium:yttrium-aluminum-garnet (Ho:YAG) and 80 W potassium titanyl phosphate lasers for rapid incision and vaporization of the prostate has resulted in renewed interest in the use of lasers for treatment of benign prostatic hyperplasia (BPH). Although long-term studies are still lacking, short-term results demonstrate that these procedures are at least as safe and effective in relieving BPH symptoms as transurethral resection of the prostate and may provide reduced morbidity. Other laser techniques, such as interstitial laser coagulation and contact laser vaporization of the prostate, have lost popularity due to complications with increased catheterization time, irritative symptoms, and infection rates. Read More

View Article

Download full-text PDF

Source
January 2007
3 Reads

Local anesthesia during interstitial laser coagulation of the prostate.

Authors:
Kalish R Kedia

Rev Urol 2005 ;7 Suppl 9:S23-8

Cleveland Urology Associates, Middleburg Heights, OH.

With the emergence of minimally invasive therapies for the management of symptoms of benign prostatic hyperplasia (BPH), as well as the reality of a changing medical economic environment, there is a need for a reliable local anesthesia protocol. The protocol described here for prostate anesthetic block is a safe, economical, and effective way to perform interstitial laser coagulation and other minor endoscopic urologic procedures in the office setting. Most patients experience little discomfort and recover quickly, with prompt return to normal activities. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1477640PMC
July 2011
3 Reads

A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.

J Urol 2006 Oct;176(4 Pt 1):1500-6

Department of Urology, Case School of Medicine, University Hospitals of Cleveland, Cleveland, Ohio 44106, USA.

Purpose: We critically evaluated the clinical outcomes and cost characteristics of alternative procedural treatment options for symptomatic benign prostatic hyperplasia.

Materials And Methods: An outcomes and cost analysis was performed for benign prostatic hyperplasia treatments, including photoselective vaporization, microwave thermotherapy, transurethral needle ablation, interstitial laser coagulation and transurethral resection. Clinical outcomes were measured by the percent improvement in American Urological Association/International Prostate Symptom Score, the maximum uroflowmetry rate and quality of life score. Read More

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S002253470601447
Publisher Site
http://dx.doi.org/10.1016/j.juro.2006.06.064DOI Listing
October 2006
6 Reads

Current role of lasers in the treatment of benign prostatic hyperplasia (BPH).

Authors:
Rainer M Kuntz

Eur Urol 2006 Jun 31;49(6):961-9. Epub 2006 Mar 31.

Department of Urology, Auguste-Viktoria-Hospital, Berlin, Germany.

Objective: Evaluate the current role of lasers in the treatment of benign prostatic hyperplasia (BPH).

Methods: The results of a MEDLINE search for randomised trials and case series of the last 5 yr and published review articles were analysed for the safety and efficacy of neodymium:yttrium aluminum garnet (Nd:YAG), potassium-titanyl-phosphate (KTP), and holmium (Ho):YAG laser prostatectomy. The analysis includes 12 reports on randomised clinical trials, 2 comparative studies, 10 review articles, and a total of >5000 patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2006.03.028DOI Listing
June 2006
2 Reads

Techniques and long-term results of surgical procedures for BPH.

Eur Urol 2006 Jun 6;49(6):970-8; discussion 978. Epub 2006 Feb 6.

Department of Urology, University-Hospital Munich Grosshadern, Ludwig-Maximilians-University, Germany.

Objective: To provide an overview on the current status of the long-term outcomes of instrumental treatment options for patients with lower urinary tract symptoms that are suggestive of bladder outlet obstruction.

Methods: Based on MEDLINE database searches, we performed a systematic review of the literature with a focus on peer-reviewed articles about surgical benign prostatic hyperplasia (BPH) therapy published between 2000 and 2005. Special emphasis was given to randomized controlled trials on long-term outcome with a minimum follow-up of five years. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2005.12.072DOI Listing
June 2006
2 Reads

Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.

Authors:

Ont Health Technol Assess Ser 2006 1;6(17):1-121. Epub 2006 Aug 1.

Objective: The Ontario Health Technology Advisory Committee asked the Medical Advisory Secretariat (MAS) to conduct a health technology assessment on energy delivery systems for the treatment of benign prostatic hyperplasia (BPH).

Clinical Need: TARGET POPULATION AND CONDITION BPH is a noncancerous enlargement of the prostate gland and the most common benign tumour in aging men. (1) It is the most common cause of lower urinary tract symptoms (LUTS) and bladder outlet obstruction (BOO) and is an important cause of diminished quality of life among aging men. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379165PMC
October 2012
42 Reads

Prospective evaluation of interstitial laser coagulation of the prostate: importance of surgical technique and patient selection.

J Endourol 2005 Oct;19(8):1012-5

Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.

Purpose: To evaluate the impact of improvements in surgical technique and patient selection on overall outcomes of interstitial laser coagulation (ILC) of the prostate and to describe our treatment algorithm.

Patients And Methods: During a 4-year period, 66 men with bothersome lower urinary-tract symptoms underwent ILC of the prostate using the Indigo 830e Diode Laser System (Ethicon Endo-Surgery). Patients were assessed preoperatively and followed prospectively. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/end.2005.19.1012DOI Listing
October 2005
2 Reads

[Transurethral resection for prostatic adenoma larger than 100 ml--preoperative treatment with interstitial laser coagulation of the prostate plus chlormadinone acetate as a treatment maneuver for safer operations].

Hinyokika Kiyo 2005 Mar;51(3):159-64

Department of Urology, Furuya Hospital.

Between August 1985 and March 2004, we performed transurethral resection of the prostate (TURP) in 18 patients with benign prostatic hyperplasia (BPH) whose prostatic volume was larger than 100 ml. We divided the patients into two groups. Group A consisted of a total of 14 cases: 10 cases whose mean prostate volume was 114 ml (100 to 137 ml) and 4 cases whose prostate volume was not measured before TURP but whose mean resected prostatic tissue weight was 113 g (105 to 118 g). Read More

View Article

Download full-text PDF

Source
March 2005
1 Read

Human prostatic tissue constituents respond differently to thermal injury induced by Nd-YAG laser ITT fiber applied ex-situ.

Rom J Morphol Embryol 1998 Jan-Dec;44(1-4):83-91

Department of Pathology, Hasharon Hospital, Petach-Tiqva, Israel.

Background And Objective: The human prostate is a glandular organ that has intervening fibromuscular elements. The objective of this study was to evaluate the thermocoagulative effect on the different components of the organ exposed to Nd-YAG laser irradiation using a new ITT optic fiber design (Interstitial Thermal Therapy).

Study Design/patients And Methods: Twelve fresh transvesical prostatectomy specimens were irradiated ex-situ at 4 to 6 sites using an ITT fiber with laser energies ranging from 900 to 4500 joules (J) applied at times ranging from 60 to 300 seconds corresponding to 10 to 15 watts. Read More

View Article

Download full-text PDF

Source
August 2005
2 Reads

Lasers in the treatment of benign prostatic hyperplasia: an update.

Curr Opin Urol 2005 Jan;15(1):55-8

Department of Urology, Royal Perth Hospital, Perth, Australia.

Purpose Of Review: Few of the original laser-based procedures from the early 1990s have withstood the test of time while some, such as holmium laser prostatectomy, have been significantly modified. New additions to the fold, such as the high-powered potassium-titanyl-phosphate (KTP) laser, use old techniques and disposables but a higher level of energy than previously. In the 12 months since September 2003, a number of important articles have appeared concerning laser prostatectomy, the subject of this review. Read More

View Article

Download full-text PDF

Source
January 2005
2 Reads

Update of the minimally invasive therapies for benign prostatic hyperplasia.

Curr Opin Urol 2005 Jan;15(1):49-53

Department of Urology, University Vita-Salute-San Raffaele, San Raffaele Hospital, Milan, Italy.

Purpose Of Review: The elevated impact benign prostatic hyperplasia has on patient quality of life has determined continuous research into the development of minimally invasive therapies aimed at restoring or preserving a good quality of life. The purpose of this review is to highlight recent developments in the field of minimally invasive treatment of benign prostatic hyperplasia, and to determine their possible impact on everyday clinical practice.

Recent Findings: Recent publications have described some interesting new therapies and provided data concerning long-term follow up and cost-effectiveness that have been lacking up until now. Read More

View Article

Download full-text PDF

Source
January 2005
1 Read

Intermittent catheterization time required after interstitial laser coagulation of the prostate.

Urology 2004 Jul;64(1):79-83

Department of Urology, Hamamatsu Rosai Hospital, Shizuoka, Japan.

Objectives: To evaluate and minimize the duration of clean intermittent catheterization (CIC) required after interstitial laser coagulation of the prostate in patients with benign prostatic hyperplasia.

Methods: Patients who did not show sufficient improvement in lower urinary tract symptoms or voiding dysfunctions with alpha-1 adrenergic blockers, and who agreed to undergo interstitial laser coagulation of the prostate, were enrolled in this study. Postoperatively, the indwelling Foley catheters were removed by the next morning. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2004.03.009DOI Listing
July 2004
1 Read

Transurethral resection versus minimally invasive treatments of benign prostatic hyperplasia: results of treatments. Our experience.

Arch Ital Urol Androl 2004 Mar;76(1):11-8

Institute of Urology, Polytechnic University of the Marche Region, Medical School, Ancona, Italy.

Objective: In this non-randomized prospective study the results of standard TURP (Transurethral Resection of the Prostate) versus other minimally invasive treatments were compared.

Materials And Methods: Among all the patients treated at our Institution for bladder outlet obstruction due to BPH (Benign Prostatic Hyperplasia) from January 1995 to June 1998, 212 patients have been evaluated; 90 patients underwent to TURP, 13 patients to TVP (Transurethral ElectroVaporization), 24 patients to TUNA (TransUrethral Needle Ablation), 71 patients to ILC (Interstitial Laser Coagulation), and 13 patients to WIT (Water-Induced Thermotherapy).

Results: TURP achieves the highest decrease of prostate volume (48. Read More

View Article

Download full-text PDF

Source
March 2004
6 Reads

Laser prostatectomy for benign prostatic obstruction.

Cochrane Database Syst Rev 2004 (1):CD001987

General Internal Medicine 111GIM, New Mexico VA Health Care System, 1501 San Pedro Drive SE, Albuquerque, New Mexico 87108, USA.

Background: Symptomatic benign prostatic obstruction is a common problem for older men. The gold standard treatment, transurethral resection of the prostate (TURP), significantly improves urinary symptoms and urinary flow. However, TURP has up to a 20% morbidity. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/14651858.CD001987.pub2
Publisher Site
http://dx.doi.org/10.1002/14651858.CD001987.pub2DOI Listing
June 2004
9 Reads

Interstitial laser photocoagulation for treatment of benign prostatic hypertrophy: outcomes and cost effectiveness.

Chang Gung Med J 2003 Nov;26(11):799-806

Department of Urology, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan, ROC.

Background: We examined the efficiency and cost effectiveness of a temperature feedback diode-laser system in the treatment of benign prostatic hypertrophy (BPH).

Methods: One hundred twenty patients with symptomatic BPH were included in this study between October 1997 and January 1998. Sixty of them were treated by transurethral resection of the prostate (TUR-P), and 60 patients were treated by temperature feedback interstitial laser coagulation (ILC). Read More

View Article

Download full-text PDF

Source
November 2003
3 Reads

Interstitial laser coagulation versus transurethral resection of the prostate for benign prostatic enlargement--a prospective randomized study.

Scand J Urol Nephrol 2003 ;37(6):494-7

Department of Urology, Lund University Hospital, Sweden.

Objective: Interstitial laser coagulation (ILC) of the prostate is a minimally invasive method for treating symptomatic benign prostatic enlargement (BPE). We performed a prospective randomized study to compare the clinical outcomes of ILC and transurethral resection of the prostate (TURP).

Material And Methods: Between December 1997 and February 2000, 38 patients with moderate-to-severe symptomatic BPE were included in the study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00365590310001773DOI Listing
May 2004
2 Reads

Interstitial laser coagulation treatment of benign prostatic hyperplasia: is it to be recommended?

J Endourol 2003 Oct;17(8):595-600

Department of Urology, University Medical Center St. Radboud, Nijmegen, The Netherlands.

Purpose: To update the clinical data on the treatment of benign prostatic hyperplasia (BPH) by interstitial laser coagulation (ILC).

Material And Methods: In addition to recent review articles, original papers published during the last 2 years were surveyed. The focus was on prospective, particularly randomized, trials and on those with long-term follow-up. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/089277903322518590DOI Listing
October 2003
1 Read

[Long-term follow-up of interstitial laser coagulation in the treatment of benign prostatic hyperplasia].

Aktuelle Urol 2003 Jan;34(1):48-51

Urologische Klinik. Klinikum Mannheim gGmbH, Universitätsklinikum, Mannheim.

Introduction: Besides standard open or transurethreal adenoma resection, less morbid interstitial laser coagulation (ILC) is an alternative therapeutical option that could reduce lower urinary tract symptoms, especially in high-risk patients. Although short-term results indicate effectiveness, reliable long-term statistics are still lacking. Therefore, to assess long-term satisfaction and overall success rate, we re-evaluated patients with a mean follow-up of 7 years after laser treatment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2003-37559DOI Listing
January 2003
1 Read

Interstitial laser coagulation of the prostate for management of acute urinary retention.

J Urol 2003 Sep;170(3):879-82

Department of Urology, Hamamatsu Rosai Hospital, Hamamatsu, Japan.

Purpose: We evaluated the clinical efficacy and benefit of interstitial laser coagulation of the prostate (ILCP) in patients with benign prostatic hyperplasia (BPH) presenting with acute urinary retention.

Materials And Methods: Patients presenting with acute urinary retention were prospectively evaluated. Patients underwent ILCP and outcomes were evaluated by post-void residual urine, maximum flow rate, International Prostate Symptom Score, and disease specific quality of life score at baseline, 1, 3, 6 and 12 months. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ju.0000082581.19298.49DOI Listing
September 2003
1 Read

Combination of interstitial laser coagulation and transurethral resection of the prostate: ex vivo evaluations.

Urology 2003 Jun;61(6):1172-6

Department of Urology, Ludwig-Maximilians-University, Munich, Germany.

Objectives: To evaluate the combination of interstitial laser coagulation (ILC) and transurethral resection of the prostate (TURP) in an ex vivo model. Perioperative bleeding is still regarded as the main complication of conventional TURP. The minimally invasive procedure ILC and the highly effective TURP seem to be a promising concept to improve hemostasis. Read More

View Article

Download full-text PDF

Source
June 2003
5 Reads

[Prevalence and preference with regard to various surgical treatments for benign prostatic hypertrophy: a survey for the Japanese endourology and ESWL society member].

Nihon Hinyokika Gakkai Zasshi 2003 May;94(4):495-502

Department of Urology, Graduate School of Medical Sciences, Kyushu University.

Background And Purpose: We conducted a questionnaire survey concerning the prevalence and preference with regard to various types of surgical treatment for benign prostatic hypertrophy (BPH), in order to gather preliminary data that may be helpful for standardizing the surgical treatment of BPH.

Method: A questionnaire survey was mailed to institutes in which a council member of the Japanese Endourology and ESWL Society was present. The questions dealt with the type and volume of surgical treatment experienced previously, and the treatments which had been performed in each institute during 2000. Read More

View Article

Download full-text PDF

Source
May 2003
2 Reads

[Interstitial laser coagulation for benign prostatic hyperplasia: clinical results of the Indigo diode laser system].

Hinyokika Kiyo 2003 Apr;49(4):195-200

Department of Urology, Kurashiki Central Hospital.

We report our experience with interstitial laser coagulation of the prostate (ILCP) using an Indigo 830j diode laser system for benign prostatic hyperplasia (BPH). From March 1998 to November 2000, we treated 45 patients between 51 and 95 years old (average 71.5) with symptomatic BPH. Read More

View Article

Download full-text PDF

Source
April 2003
3 Reads

Interstitial laser coagulation of the prostate: minimally invasive therapy for benign prostatic hyperplasia.

Authors:
J C Williams

Surg Technol Int 1998 ;7:317-20

Division of Urologic Surgery, University of Pittsburgh, Pa., Valley Urological Associates, Sewickley, Pa.

View Article

Download full-text PDF

Source
October 2012
2 Reads

Interstitial laser coagulation versus transurethral prostate resection for treating benign prostatic obstruction: a randomized trial with 2-year follow-up.

Urology 2003 Mar;61(3):573-8

Urological Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44122, USA.

Objectives: To investigate whether interstitial laser coagulation (ILC) is as effective and as safe as transurethral resection of the prostate (TURP). The treatment of choice for bladder outflow obstruction secondary to benign prostatic hyperplasia is TURP. However, ILC is a less invasive outpatient procedure that may be as effective and safe as TURP. Read More

View Article

Download full-text PDF

Source
March 2003
2 Reads

[Interstitial laser coagulation of the prostate].

Authors:
Michitaka Yajima

Nihon Rinsho 2002 Dec;60 Suppl 11:388-91

Yajima Urology Clinic.

View Article

Download full-text PDF

Source
December 2002
1 Read

Interstitial laser coagulation in the treatment of benign prostatic hyperplasia using a diode laser system: results of an evolving technology.

Prostate Cancer Prostatic Dis 1999 May;2(3):148-154

Department of Urology, University Hospital Nijmegen, The Netherlands.

Interstitial laser coagulation (ILC) treatment is a recent technique in the treatment of BPH that is evolving rapidly. The results of a prospective randomised study vs transurethral resection of the prostate (TURP) is presented as well as results of patients treated with a temperature sensing laser system. The first study included 44 patients treated in a prospective randomised study (randomisation ILC vs TURP=2:1) comparing changes in objective and subjective parameters. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.pcan.4500306DOI Listing
May 1999
1 Read

Laser therapy for benign prostatic hyperplasia: a review of recent developments.

Curr Opin Urol 2003 Jan;13(1):39-44

Department of Urology, Tauranga Hospital, Tauranga, New Zealand.

Purpose Of Review: Over the past 10-15 years a variety of endoscopic laser techniques have evolved for the treatment of benign prostatic hyperplasia. The laser is merely an energy source with the ability to coagulate, incise, vaporize, resect and dissect (enucleate), all fundamentally different procedures. Generalization regarding "laser prostatectomy" is therefore inappropriate. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.mou.0000049387.71470.d1DOI Listing
January 2003
2 Reads

Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia.

BJU Int 2002 Dec;90(9):853-62

Department of Surgery, Section of Urology, Kolding Hospital, Kolding, Denamark.

Objective: To compare the efficacy and frequency of complications of transurethral interstitial laser coagulation (ILC) and transurethral microwave thermotherapy (TUMT) with transurethral resection or incision of the prostate (TURP/TUIP) in patients with symptomatic benign prostatic hyperplasia (BPH).

Patients And Methods: Forty-eight patients were randomized to undergo ILC, 46 to TUMT and 24 to TURP/TUIP; they were followed for 6 months and the outcome analysed on an intention-to-treat basis.

Results: At 6 months the symptom scores and maximum urinary flow rate (Qmax) had improved significantly in all groups. Read More

View Article

Download full-text PDF

Source
December 2002
4 Reads

Interstitial laser coagulation combined with minimal transurethral resection of the prostate for the treatment of benign prostatic hyperplasia.

J Endourol 2002 Aug;16(6):387-90

Department of Urology, Ludwig-Maximilians-Universitaet, Munich, Germany.

Background: Transurethral resection of the prostate (TURP) represents the gold standard in the surgical treatment of benign prostatic hyperplasia (BPH). However, this method still has significant morbidity mainly associated with irrigation fluid absorption and blood loss.

Patients And Methods: A combination of interstitial laser coagulation (ILC) with limited TURP was established to reduce specific risks of transurethral resection and was applied in 41 patients with bladder outlet obstruction caused by BPH. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/089277902760261446DOI Listing
August 2002
2 Reads

Cost-effectiveness of new treatments for benign prostatic hyperplasia: results of a randomized trial comparing the short-term cost-effectiveness of transurethral interstitial laser coagulation of the prostate, transurethral microwave thermotherapy and standard transurethral resection or incision of the prostate.

Scand J Urol Nephrol 2002 ;36(4):286-95

Department of Surgery, Section of Urology, Kolding Hospital, Denmark.

Objectives: To compare the short-term cost-effectiveness of ILC and TUMT with that of transurethral resection or incision of the prostate in patients with symptomatic benign prostatic hyperplasia.

Material And Methods: One hundred and eighteen patients were randomized to ILC, TUMT and TUR-P/TUI-P in 2:2:1 fashion. The use of resources within the first 6 months of follow-up were measured and the cost of treatment for each patient were calculated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/003655902320248263DOI Listing
November 2002
4 Reads

Interstitial laser coagulation and biodegradable self-expandable, self-reinforced poly-L-lactic and poly-L-glycolic copolymer spiral stent in the treatment of benign prostatic enlargement.

J Endourol 2002 Jun;16(5):311-5

Department of Urology, Tampere University Hospital, Medical School, University of Tampere, Tampere, Finland.

Background And Purpose: Interstitial laser coagulation of the prostate (ILCP) induces necrosis, edema, and an increased risk of postoperative urinary retention. The object here was to evaluate the efficacy, safety, and utility of a new self-expandable self-reinforced (SR) PLGA copolymer(lactic:glycolic ratio 80/20) spiral stent inserted after ILCP to promote voiding. The SR-PLGA stent has a degradation time of 2 to 2. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/089277902760102811DOI Listing
June 2002
1 Read

[Choice of YAG-Nd mode for conduction of interstitial laser coagulation in benign prostatic hyperplasia].

Urologiia 2001 Jul-Aug(4):33-6

Basing on the results of fundamental and experimental investigations, we have selected the YAG-Nd laser mode for interstitial laser coagulation (ILC) of the prostate using laser unit LAMIN-1 made in Russia. The experiments were performed on cadaver prostates (3 macropreparations of human prostate 50-80 cm3 in volume). The samples were exposed to laser radiation after their immersion into 5% glucose solution. Read More

View Article

Download full-text PDF

Source
April 2002
1 Read

Expansion and bioabsorption of the self-reinforced lactic and glycolic acid copolymer prostatic spiral stent.

J Urol 2001 Sep;166(3):919-22

Department of Urology, University Hospital and Medical School, University of Tampere, Tampere, Finland.

Purpose: Self-reinforced bioabsorbable stents can be made self-expanding due to the viscoelastic memory of the oriented bioabsorbable materials. A new self-expandable self-reinforced copolymer of lactic/glycolic acid, lactic/glycolic molar ratio 80:20 stent was developed to prevent postoperative urinary retention after procedures that induced prostatic edema. In in vitro experiments the expansion rate has been up to 100% during the first few hours at body temperature. Read More

View Article

Download full-text PDF

Source
September 2001
1 Read

Perioperative prediction by MRI of prostate volume six to twelve months after laser-induced thermotherapy of benign prostatic hyperplasia.

J Magn Reson Imaging 2001 Jan;13(1):64-8

Institute of Clinical Radiology, Klinikum Grosshadern, Ludwig-Maximilians-Universität, D-81377 Muenchen, Germany.

The purpose of this study was to predict prostate volume outcome 6-12 months after interstitial, laser-induced thermotherapy (LITT) for benign prostatic hyperplasia (BPH) on the basis of prostate magnetic resonance (MR) images obtained within 48 hours before and after LITT. Twenty patients (age, 64.2 +/- 7. Read More

View Article

Download full-text PDF

Source
January 2001
1 Read

Comparative study of transurethral laser prostatectomy versus transurethral electroresection for benign prostatic hyperplasia.

Int J Urol 2000 Oct;7(10):373-7

Department of Urology, Osaka City University Hospital, Osaka, Japan.

Background: Transurethral resection of the prostate (TURP) is the gold standard treatment for benign prostatic hyperplasia (BPH). Recently, less invasive transurethral laser prostatectomy, such as visual laser ablation (VLAP) or interstitial laser coagulation (ILCP), have been developed. Herein, we investigated the efficacy of VLAP and ILCP compared to TURP. Read More

View Article

Download full-text PDF

Source
October 2000
2 Reads

A randomised study to evaluate the efficacy of a biodegradable stent in the prevention of postoperative urinary retention after interstitial laser coagulation of the prostate.

Scand J Urol Nephrol 2000 Aug;34(4):262-6

Department of Urology, Helsinki University Central Hospital, Finland.

Objective: Interstitial laser coagulation (ILC) of the prostate induces necrosis, oedema and increased risk for postoperative urinary retention. The present randomized study was carried out to investigate the feasibility and efficacy of a biodegradable self-reinforced polyglycolic acid (SR-PGA) stent in preventing postoperative urinary retention and the need for prolonged catheterization after ILC treatment.

Material And Methods: 35 males with benign prostatic enlargement (BPE) entered the study: 21 in the ILC + stent group and 14 in the ILC group without a stent. Read More

View Article

Download full-text PDF

Source
August 2000
2 Reads

Long-term follow-up of laser treatment for lower urinary tract symptoms suggestive of bladder outlet obstruction.

Urology 2000 Oct;56(4):604-9

Department of Urology, University Medical Center St. Radboud, Nijmegen, The Netherlands.

Objectives: The long-term results of different laser technologies in the management of lower urinary tract symptoms (LUTS) suggestive of bladder outlet obstruction (BOO) are not well known. We studied the durability of the effect of laser prostatectomy and tried to identify the factors predictive of treatment outcome.

Methods: Between December 1992 and November 1996, 190 patients underwent laser prostatectomy because of LUTS suggestive of BOO. Read More

View Article

Download full-text PDF

Source
October 2000
1 Read

Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study.

J Urol 2000 Oct;164(4):1206-11

Department of Urology, Kurashiki Central Hospital, Kurashiki, Japan.

Purpose: Treatment for benign prostatic hyperplasia (BPH), including minimally invasive therapy, can impair the quality of life. We prospectively determined the impact of 4 different interventional therapies on quality of life and sexual function.

Materials And Methods: A total of 173 patients were prospectively evaluated between February 1995 and August 1997. Read More

View Article

Download full-text PDF

Source
October 2000

Treatment of a benign prostatic hyperplasia by Nd:YAG laser - own experience.

Eur Urol 2000 Aug;38(2):194-8

Urological Clinic, Post-Graduate Medical Educational Center, Warsaw, Poland.

Objectives: To evaluate the effectiveness and safety of visual laser ablation (VLAP) and interstitial laser coagulation (ILCP) versus transurethral resection of the prostate (TURP).

Patients And Methods: Altogether 259 consecutive patients with symptomatic benign prostatic hyperplasia (BPH) were treated by VLAP (n = 117), ILCP (n = 30) or TURP (n = 112). VLAP was carried out using both contact and noncontact techniques, whereas ILCP using the technique described by Muschter. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000020279DOI Listing
August 2000
2 Reads

Interstitial laser coagulation technique. Executive summary.

Authors:
M S Steiner

World J Urol 2000 Apr;18 Suppl 1:S4-5

In March 1999, it was again my privilege to moderate a meeting of distinguished colleagues organized by Indigo Medical, Inc. as their BPH Advisory Panel. This executive summary highlights the most important conclusions of our day-long session. Read More

View Article

Download full-text PDF

Source
April 2000
2 Reads

Evaluation of interstitial diode laser therapy for treatment of benign prostatic hyperplasia.

Tech Urol 1999 Dec;5(4):202-6

Department of Urology, St. Vincent's Hospital, Melbourne, Australia.

In the last decade, a number of new device technologies were developed for benign prostatic hyperplasia (BPH) therapy. These technologies were introduced in an effort to reduce the morbidity of BPH therapy associated with conventional electrocautery transurethral resection of the prostate (TURP). While morbidity is reduced, the aim of new therapy is to achieve near equivalence in efficacy of outcome measures, namely, improved voided flow rate and reduced symptom score. Read More

View Article

Download full-text PDF

Source
December 1999
1 Read

Interstitial laser coagulation in patients with lower urinary tract symptoms from benign prostatic obstruction: treatment under sedoanalgesia with pressure-flow evaluation.

Authors:
L Daehlin H Hedlund

BJU Int 1999 Oct;84(6):628-36

Division of Urology, Department of Surgery, University of Bergen, Bergen.

Objectives: To evaluate the effects on lower urinary tract symptoms and pressure-flow variables after interstitial laser coagulation (ILC) of the prostate using the Indigo diode laser system (Indigo, Palo Alto, USA).

Patients And Methods: Forty-nine men (median age 68 years, range 52-80) were assessed using symptom scores and voiding variables before and at 3 and 12 months after ILC. A subset of 26 men (median age 68 years, range 63-72) underwent pressure-flow measurements before and at 6 months after ILC. Read More

View Article

Download full-text PDF

Source
October 1999
1 Read

Interstitial laser coagulation in benign prostatic hyperplasia: A critical evaluation after 2 years of follow-Up.

Urol Int 1999 ;62(2):76-80

Department of Urology, Klinikum Mannheim, University of Heidelberg, Mannheim, Germany.

Since 1993 we have prospectively followed a cumulative cohort of males with benign prostatic hyperplasia and symptomatic bladder outlet obstruction who underwent interstitial laser coagulation (ILC) of the prostate. We evaluated the safety and efficacy of ILC with respect to relief of symptoms and bladder outlet obstruction. In addition to the critical evaluation of our clinical results, the perineal and transurethral approaches were investigated as they may make a substantial impact on the overall success rate, including prostate size, number of sticks per prostate volume and type of application. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000030362DOI Listing
October 1999
1 Read